Accessing the US Market – Key Development Considerations and Options for Market Entry for Korea-Based Biopharma Companies

GT Shareholder Wayne Elowe and Mi Young (Audrey) Lee will be speaking at the seminar "Accessing the US Market – Key Development Considerations and Options for Market Entry for Korea-Based Biopharma Companies" on September 30. This seminar is tailored for Korean biopharma firms aiming to achieve FDA approval and enter the U.S. market. This hands-on event will feature expert consultants and legal advisors who will provide valuable insights into successful development strategies and market entry techniques. The seminar will cover crucial topics such as enhancing asset value through U.S. development strategies and ensuring readiness for U.S. regulatory and clinical pharmacology requirements, all aimed at maximizing the potential of Korean biopharma products in the U.S. market. A networking reception will take place after starting at 5:30 p.m.